Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

140.36-0.34 (-0.24%)

At close: 4:00PM EDT

140.36 0.00 (0.00%)
After hours: 04:44PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	140.70
Open	139.76
Bid	137.55 x 800
Ask	143.11 x 800
Day's Range	138.85 - 140.69
52 Week Range	126.01 - 189.00
Volume	585,215
Avg. Volume	725,235

Market Cap	8.613B
Beta (5Y Monthly)	0.95
PE Ratio (TTM)	204.01
EPS (TTM)	0.69
Earnings Date	Nov 01, 2021 - Nov 05, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	205.47

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-21% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JAZZ

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Jazz Pharmaceuticals plc
JAZZ: Raising target price to $149.00JAZZ PHARMACEUTICALS PLC has an Investment Rating of BUY; a target price of $149.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
12 days agoArgus Research

All

News

Press Releases

Research Reports

Zacks
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Insider Monkey
Hedge Funds Are Cashing Out Of Jazz Pharmaceuticals Plc (JAZZ)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]
Motley Fool
September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy
September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.